Analysis of the effects of azithromycin combined with budesonide and children’s Chaiqiao Qingre granules on the efficacy and improvement of clinical symptoms of mycoplasma pneumonia in children
Abstract
To explore the effects of azithromycin combined with budesonide and children’s Chaiqiao Qingre granules on the efficacy and improvement of clinical symptoms of mycoplasma pneumonia in children. A retrospective analysis was conducted on the case data of 115 pediatric patients diagnosed with mycoplasma pneumonia admitted to our pediatric department between February 2023 and February 2024. Based on their treatment regimen, the patients were categorized into an observation group (OG) (treated with azithromycin in combination with budesonide and Xiao’er Chiqiao Qingre Granules, totaling 60 cases) and a control group (CG) (treated with azithromycin combined with budesonide, 55 cases). A comparative analysis was performed between the 2 groups regarding the total treatment effectiveness, duration until relief of clinical symptoms, alterations in immunoglobulin levels, pulmonary function indicators, serum C-reactive protein (CRP), serum procalcitonin (PCT) levels before and after treatment, and the incidence of adverse reactions. The total treatment effectiveness of OG markedly surpassed that of the CG (96.67% vs 80.00%) (P .05). Azithromycin combined with budesonide and children’s Chaiqiao Qingre granules can effectively improve the clinical symptoms of children with mycoplasma pneumonia, enhance immune function, improve pulmonary function, reduce inflammatory response, and reduce the incidence of adverse reactions, which is worthy of clinical promotion and application.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.